Agenda
GULBENKIAN.PT

APAV - Associação Portuguesa de Apoio à Vítima

Support to APAV - Associação Portuguesa de Apoio à Vítima for the continuation of the CARE Plus Network, specialized in supporting children and young people victims of sexual violence and their families, under the Gulbenkian Sustainable Development Program.
Type of direct beneficiary
Coletiva
Type of grant
Subsídio
Area of intervention
Charity
Date
2020 - 2021
Allocated amount
160.415,61 €
Direct beneficiary region
Portugal
Final beneficiary region
Portugal

Cookies settings

Cookies Selection

This website uses cookies to improve your browsing experience, security, and its website performance. We may also use cookies to share information on social media and to display messages and advertisements personalised to your interests, both on our website and in others.

These cookies are used to enhance your browsing experience, security and our website's performance, allowing you to access the main features of the website. Therefore, they are always enabled. This type of cookies includes cookies that allow you to be remembered as you browse the website during a single session.

These cookies collect information about the use of the website to improve the services provided and to evaluate the performance of the website. Some of these cookies may be used to test pages or the functionality of the website by measuring the reaction of users. These cookies may be our own and / or owned by third parties.

These cookies are third-party cookies that allow to connect to social media and share multimedia content from our website on those networks. Some of these cookies help us to adapt advertising outside of our website to the interests of the users. By disabling these cookies, it will no longer be possible to directly share our content in any social media

For more information about cookies and the processing of your personal data, please see the Privacy and Cookies Policy. You can change your cookie settings at any time through the link at the bottom of the page.